Compare

Ceribell, Inc. vs Vaso Corp vs Outset Medical, Inc. vs Iridex Corp

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearCeribell, Inc.
CBLL
Vaso Corp
VASO
Outset Medical, Inc.
OM
Iridex Corp
IRIX
Year ended2025-12-312025-12-312025-12-312026-01-03
Revenue$89.06M$89.10M$119.48M$52.67M
Revenue growth (YoY)+36.1%+2.7%+5.1%+8.2%
Gross margin87.9%61.4%39.1%36.5%
Operating margin-65.6%-3.2%-55.8%-4.9%
Net margin-60.0%1.8%-68.3%-8.4%
Net income-$53.41M$1.57M-$81.65M-$4.44M
EPS (Diluted)-$1.46$0.01-$5.37-$0.26
Operating cash flow-$40.81M$9.27M-$46.33M-$2.12M
Free cash flow-$41.58Mn/a-$47.12M-$2.26M
Cash & equivalents$40.48M$35.05M$35.01M$6.03M
Total assets$195.80M$88.35M$264.50M$29.15M
Total liabilities$40.47Mn/a$137.54M$24.23M
Shareholders' equity$155.34M$29.43M$126.95M$4.92M
Return on year-end equity-34.4%5.3%-64.3%-90.1%
Shares outstanding37.49M175.95M18.17M17.31M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearCeribell, Inc.Vaso CorpOutset Medical, Inc.Iridex Corp
Latest$89.06M
Ended 2025-12-31
$89.10M
Ended 2025-12-31
$119.48M
Ended 2025-12-31
$52.67M
Ended 2026-01-03
1 year earlier$65.44M
Ended 2024-12-31
$86.77M
Ended 2024-12-31
$113.69M
Ended 2024-12-31
$48.67M
Ended 2024-12-28
2 years earlier$45.23M
Ended 2023-12-31
$81.02M
Ended 2023-12-31
$130.38M
Ended 2023-12-31
$51.87M
Ended 2023-12-30
3 years earliern/a$79.29M
Ended 2022-12-31
$115.38M
Ended 2022-12-31
$56.97M
Ended 2022-12-31
4 years earliern/a$75.58M
Ended 2021-12-31
$102.60M
Ended 2021-12-31
$53.90M
Ended 2022-01-01